FRANKFURT (Reuters) – German drugs and pesticides company Bayer said the economic downturn has prompted it to take a tougher stance in talks to settle claims its glyphosate-based weedkillers cause cancer, even as its earnings rose. The pandemic has significant... More »
(Reuters) – The U.S. Environmental Protection Agency and the Justice Department said a federal appeals court should reverse a lower court verdict finding Bayer AG liable in the case of a California man who blamed its Roundup weed killer for his cancer. The gov... More »
(This October 6 story has been refilled to correct “until February” to “until further notice” in headline and “new court date” to “court status conference” in paragraphs 1 & 6) FRANKFURT (Reuters) – A pending U.S. lawsuit over claims related to Bayer’s (BAYGn.... More »
FRANKFURT (Reuters) – German drugmaker Bayer on Tuesday said it is to spend more than 25 billion euros ($27.22 billion) on research and development at its agriculture unit over the next 10 years. “Agriculture needs to feed a growing world without starving the ... More »
NEW YORK/FRANKFURT (Reuters) – Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said, dismissing a report to that effect which drove its shares as much as 11% high... More »
SYDNEY (Reuters) – Sydney’s city council said on Friday it was reviewing its weed management, which included the use of Bayer AG’s Roundup, after other councils in Australia began cutting ties with the product amid concerns about possible links to cancer. The ... More »
NEW YORK (Reuters) – Bayer AG disputed accusations in a new Netflix documentary that claims medical device makers and the U.S. Food and Drug Administration placed profits before patient safety. The company, in a statement released Thursday night, said the docu... More »
NEW YORK (Reuters) – Life sciences company Bayer AG said on Friday it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device that made the business no longer sustainable. The dec... More »
(Reuters) – The U.S. Food and Drug Administration (FDA) on Monday slapped restrictions on the sale of Bayer AG’s implanted birth control device Essure, two years after the agency put a severe warning label on the product. The FDA said here some women were not ... More »
FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014. REUTERS/Ina Fassbender/File Photo (Reuters) – A Pennsylvania state court judge on Tuesday overturned a $27.8 million jury aw... More »
LEVERKUSEN, Germany (Reuters) – Bayer is seeking to defend its pharmaceuticals business that will be diluted in importance by the takeover of Monsanto and faces a threat to revenues in 2024 when the blockbuster heart drug Xarelto loses its patent. The firm’s p... More »
BASF has agreed to buy seed and herbicide businesses from Bayer for 5.9 billion euros ($7 billion) in cash, as Bayer tries to convince competition authorities to approve its planned acquisition of Monsanto. More »
BASF (BASFn.DE) will take a look at further assets coming onto the market after agreeing to buy seeds and herbicide businesses from Bayer (BAYGn.DE) for 5.9 billion euros ($7 billion), its chief executive said. More »
Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and heart attacks in patients with severe atherosclerosis by 24 percent, raising the prospects of billions more in sales. More »
A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding. More »
CHICAGO The agricultural unit of German chemicals company Bayer AG will halt future U.S. sales of an insecticide that can be used on more than 200 crops after losing a fight with the U.S. Environmental Protection Agency, the company said on Friday. Bayer lost ... More »
The first electronic automatic injector to deliver a drug for the most common form of multiple sclerosis received approval from the U.S. Food and Drug Administration on Friday. The injection delivers Betaseron, a disease-modifying drug approved 22 years ago by... More »
